These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9601832)

  • 1. [Use of drug therapy in hyperlipidemia in patients after myocardial infarct in the Czech Republic].
    Widimský J; Lánská V; Jurán F; Leisser J; Vanĕk P; Spírek A; Koval Z
    Vnitr Lek; 1997 Apr; 43(4):191-4. PubMed ID: 9601832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacotherapy in patients with ischemic heart disease and diabetes mellitus in 1998 in the Czech Republic].
    Widimský J; Jurán F; Leisser J; Vanĕk P; Lánská V
    Vnitr Lek; 1999 Dec; 45(12):696-702. PubMed ID: 10951843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrates or statins and lipid plasma levels in 245 patients treated with highly active antiretroviral therapy. Aquitaine Cohort, France, 1999-2001.
    Bonnet F; Balestre E; Thiébaut R; Mercié P; Dupon M; Morlat P; Dabis F;
    HIV Med; 2004 May; 5(3):133-9. PubMed ID: 15139977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.
    EUROASPIRE II Study Group
    Eur Heart J; 2001 Apr; 22(7):554-72. PubMed ID: 11259143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of long-term cardiac training on lipids concentration in patients with chronic heart ischemic disease treated with simvastatin].
    Kałka D; Sobieszczańska M; Kopka L; Marciniak W; Zawadzka-Bartczak E; Bak A; Popielewicz-Kautz A; Korzeniowska J; Janczak J; Adamus J
    Pol Merkur Lekarski; 2007 Feb; 22(128):101-6. PubMed ID: 17598652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of simple lipid treatment goals in patients with atherosclerotic disease.
    Svilaas A; Walsöe HK; Ose L
    Nutr Metab Cardiovasc Dis; 2000 Apr; 10(2):71-8. PubMed ID: 10919171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
    Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I
    Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fenofibrate 250 SR Pharmavit in patients with mixed hyperlipoproteinemia. Results of a study of 189 patients from 13 centers in the Czech Republic].
    Ceska R; Stulc T
    Cas Lek Cesk; 2000 Jun; 139(12):369-73. PubMed ID: 10953407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypolipidemic effects of alisat and lipostabil in patients with diabetes mellitus].
    Mel'chinskaia EN; Gromnatskiĭ NI; Kirichenko LL
    Ter Arkh; 2000; 72(8):57-8. PubMed ID: 11019431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organization.
    Cooke CE; Hammerash WJ
    Clin Ther; 2006 Apr; 28(4):591-9. PubMed ID: 16750470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ciprofibrate in the treatment of combined hyperlipoproteinemia. Results in more than 600 patients from 23 centers in the Czech Republic].
    Ceska R; Kvasnicka T; Haas T; Soska V; Vaverková H
    Vnitr Lek; 2000 Mar; 46(3):157-60. PubMed ID: 11048518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achieving vascular risk factor targets: a survey of a London general practice.
    Levine AP; Mikhailidis DP; Moross T; Benson K; Gor M
    Angiology; 2008; 59(1):36-46. PubMed ID: 18319220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyslipidemia and anemia in chronically hemodialyzed patients.
    Malik J; Svobodová J; Tuka V; Mokrejsová M; Tesar V
    Prague Med Rep; 2007; 108(2):177-84. PubMed ID: 18225644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipids and acute coronary syndromes].
    Stejfa M
    Vnitr Lek; 2000 Sep; 46(9):520-5. PubMed ID: 11344644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary prevention of coronary artery disease with lipid-lowering drugs].
    Delahaye F; De Gevigney G
    Ann Med Interne (Paris); 2001 Apr; 152(3):184-7. PubMed ID: 11431578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of patients with hypertriglyceridemia].
    Rozhkova TA; Kukharchuk VV; Titov VN; Iarovaia EB; Kotova LA; Malyshev PP; Ameliushkina VA
    Ter Arkh; 2009; 81(9):29-33. PubMed ID: 19827649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of hyperlipidemia. Guidelines for treatment of hyperlipidemia for secondary prevention of ischemic heart disease].
    Ose L
    Tidsskr Nor Laegeforen; 1995 Nov; 115(29):3629-31. PubMed ID: 8539720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Examination and treatment of dyslipemia after myocardial infarction--are the goals achieved?].
    Kanstrup H; Lassen JF; Heickendorff L; Larsen ML
    Ugeskr Laeger; 2001 Nov; 163(47):6593-7. PubMed ID: 11760542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of dyslipidaemia in high-risk patients: too little, too late.
    Barter P
    Int J Clin Pract Suppl; 2002 Jul; (130):15-9. PubMed ID: 12296602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.